january 8, 22:46
Following the agreement reached between the European Commission (EC) and pharmaceutical companies on the supply of additional doses of BioNTech/Pfizer Covid-19 vaccine, Latvia has decided to purchase up to 1.4 million doses, reports LSM's Latvian language service.
The decision was announced on Friday, January 8, by Prime Minister Krišjānis Kariņš, and coincided with Health Minister Daniels Pavļuts' first day in his new job.
An agreement had previously been reached for the delivery of fewer than 200,000 doses of the BioNTech/Pfizer vaccine. Latvia has so far received 23,400 doses, with a smaller delivery of 6,825 planned for the beginning of next week, with Kariņš expressing frustration that vaccination is not taking place more quickly.